Donepezil-Hydrochloride shortage — AU supply status & alternatives

Donepezil-Hydrochloride

ATC N06DA02

Anticipated · Australia

Aridon Apn

Anticipated · 🇦🇺 Australia & also short in🇨🇦 CA🇮🇹 IT

Anticipated shortage

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

Rivastigmina

◷ Expected back

Jan 2027

Sponsor est. via TGA

Product attributes reference data we hold

Active ingredient (INN)	Donepezil-Hydrochloride

Brand names	Aridon Apn

ATC level 5	N06DA02

ATC level 4	N06DA

Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper

Controlled substance	No

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Verified timeline regulator events

🇦🇺 13 Nov 2026

low reported

🇦🇺 7 Aug 2026

low reported

🇦🇺 21 Apr 2026

high reported

🇮🇹 22 Mar 2026

medium reported

🇮🇹 11 Feb 2026

medium reported

🇮🇹 26 Jan 2026

medium reported

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.